A strong IP regime is critical for Malaysia

PHARMACEUTICAL companies have been accused of making slight modifications to their drugs to extend a patent life span.

This has resulted in calls for the government to not recognise process methods for patenting, and allowing only molecular patents.

Get 30% off with our ads free Premium Plan!

~~RM13.90/month~~
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

~~RM12.33/month~~
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

Free Trial

For new subscribers only

Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.

Report it to us.

What is the issue about?

Spelling and grammatical error

Factually incorrect

Story is irrelevant

Email (optional)